Industry News
Medical Device Industry News
Dr Robert Alexander Joins T3D Therapeutics’ Scientific Advisory Board
Alzheimer's disease expert Dr Robert Alexander will help shape the future development path of T3D Therapeutics' lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer's patients.
The Crossroads of a Revolution: Medical Device Design Meets Disruption | By Steve Levine, Senior Director, Virtual Human Modeling, Dassault Systèmes
Explore how the intersection of medical device design and disruptive technologies is reshaping the healthcare industry. Discover how new players armed with AI-driven devices and advanced manufacturing tools are pushing boundaries and revolutionizing the future
Europe $3.53 Bn Sleep Apnea Devices Markets 2024-2032 by Types, Therapeutic Devices, Diagnostic Devices, End User, and Company Analysis
Europe sleep apnea devices market turned into US$ 1.81 billion in 2023 and is expected to reach US$ 3.53 billion by 2032, with a CAGR of 7.70% from 2024 to 2032.
Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round
The landmark investment in dental artificial intelligence enables Pearl to further expand its dental AI solutions and meaningfully improve oral health outcomes for patients.
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO
Samsung Ventures Among Top Investors Backing AI Imaging Acquisition Market Leader Subtle Medical – Bringing Total Series B to Over $30 Million
The funds will primarily support accelerating US and global sales initiatives and expediting the launch of new AI-driven products notes Subtle Medical.
Tampa General Hospital Researchers Develop Innovative Device That Expands Access to Heart Transplants
"Our goal is to expand access to world-class care and save more lives," said John Couris, president and CEO of Tampa General Hospital. "With innovative approaches to transplantation, we can extend the life of critical
Doug Cassidy Appointed President of the Deep 6 AI Precision Research Ecosystem, the Largest Network of Sites and Sponsors Using AI To Accelerate Research
"Doug Cassidy, formerly our SVP and GM of healthcare organizations, has led the growth of our Ecosystem—from the first site, Cedars-Sinai in 2017, to the launch of our life sciences vertical in 2021, to now,"
Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure
The system has shown a remarkable ability to boost performance and induce cardiac repair mechanisms in subjects with heart failure.
Novo Holdings Leads $105 Mil Financing of Magenta Medical | To Support FDA Approval for World’s Smallest Heart Pump
Novo Holdings reports the funds will be used to advance Magenta’s US clinical programs to support the FDA’s approval of the Elevate™ System, the world’s smallest heart pump.
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology
“This FDA clearance marks another milestone for Asensus Surgical and represents an additional indication expansion in the U.S. market,” said Anthony Fernando, Asensus Surgical President and CEO. “The Senhance System's precision and advanced digital capabilities
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this
Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class
"For the first time, we are able to imagine and generate chemically synthesized biologics at scale and with increasing programmability, offering a new class of medicines with transformative potential," said Avak Kahvejian, Ph.D., Co-Founder and
Enterprise Therapeutics Doses First Person with Cystic Fibrosis in Phase 2 Trial for Novel Therapy ETD001
Dr John Ford, CEO, Enterprise Therapeutics, said: “The dosing of the first person with CF in our Phase 2a trial of ETD001 represents an incredible milestone, testament to Enterprise’s dedication to advancing a novel approach
Biolyst Scientific Announces New Brand Name to Encompass EMS and Azer | Will Deepen Offerings to Clinical and Research Lab Customers
The new name, ‘Biolyst,’ reflects the essential part the company plays in the Life Sciences discoveries that make life better for all. ‘Bio’ signals where impact is felt – in enhancing and extending life –
Paige Reports 3 UK-Based Hospital Systems Exploring the Power of their AI for Diagnosing Prostate Cancer in Live Clinical Settings
The Paige Prostate Suite is a system of diagnostic AI applications designed to help pathologists detect, grade and measure tumours in prostate biopsies and tissue samples. Pathologists at these three hospital systems are assessing how
Wolters Kluwer Health Launches ClinicalPulse™ | A Simplified Continuing Education Solution for Nurse Practitioners
Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. “In the current healthcare landscape, NPs are facing demanding workloads paired with staying current on the latest medical evidence to ensure
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking
Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Market
Avenacy's Palonosetron Hydrochloride Injection, USP is available in 0.25 mg/5 mL (0.05 mg per mL) single-dose vials. In line with Avenacy’s mission to champion patient safety and streamline patient care, Palonosetron Hydrochloride Injection, USP will
Agilent Technologies to Acquire North American CDMO BIOVECTRA
BIOVECTRA and Agilent Technologies are fully integrated CDMOs with state-of-the-art facilities that follow current Good Manufacturing Practices (cGMP), a high standard for methods, facilities, and controls used in manufacturing, processing, and packaging of active pharmaceutical